Andrew Balo
2010
In 2010, Andrew Balo earned a total compensation of $913.3K as Sr. V.P., Clinical Regulatory Affairs at DexCom, a 146% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $135,720 |
|---|---|
| Option Awards | $500,905 |
| Salary | $261,000 |
| Other | $15,689 |
| Total | $913,314 |
Balo received $500.9K in option awards, accounting for 55% of the total pay in 2010.
Balo also received $135.7K in non-equity incentive plan, $261K in salary and $15.7K in other compensation.
Rankings
In 2010, Andrew Balo's compensation ranked 5,635th out of 10,439 executives tracked by ExecPay. In other words, Balo earned more than 46.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,635 out of 10,439 | 46th |
Division Manufacturing | 2,043 out of 3,837 | 47th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 304 out of 667 | 54th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 145 out of 373 | 61st |
Industry Surgical and Medical Instruments and Apparatus | 76 out of 240 | 68th |
Source: SEC filing on April 18, 2011.
Balo's colleagues
We found four more compensation records of executives who worked with Andrew Balo at DexCom in 2010.